Protective TGFβ2/SMAD3 axis identified by TWAS in papillary thyroid cancer
Endocrine-Related Cancer · 01.08.2026 · 33 (8)
DOI: 10.1530/erc-25-0405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 15.07.2026. Verfasst von Qinnan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Fifth People's Hospital of Shanghai Fudan University , Shanghai, China. Hauptthemen laut MEDLINE: Smad3 Protein, Transforming Growth Factor beta2, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Although generally indolent, a subset shows aggressive behaviour. Furthermore, the genetic heterogeneity of PTC is not fully explained by known driver mutations, underscoring the need to identify additional susceptibility genes and regulatory mechanisms. To identify additional susceptibility genes and regulatory mechanisms, we integrated transcriptome-wide association studies (TWAS) with summary-data-based Mendelian randomisation (SMR), joint/conditional testing (JCT), and colocalisation analyses across multiple independent cohorts, followed by heterogeneity in dependent instruments (HEIDI) test. Gene prioritisation analyses consistently highlighted TGFB2 and SMAD3 as candidate susceptibility genes for PTC, with SMR supporting putative protective effects. Besides, GEPIA confirmed the positive correlation between TGFB2 and SMAD3 expression in TCGA-THCA. Functional experiments in TPC-1 cells showed that TGFβ2 treatment inhibited cell proliferation and migration, induced apoptosis, and resulted in G0/G1 cell-cycle arrest, accompanied by increased SMAD3 phosphorylation, suggesting activation of canonical TGFβ signalling. Collectively, these findings bridge population-based genetic inference with mechanistic validation and suggest convergent evidence supporting a tumour-suppressive role of the TGFβ2/SMAD3 axis in PTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Fifth People's Hospital of Shanghai Fudan University , Shanghai, China.
- Department of Thyroid and Breast Surgery, Fifth People's Hospital of Shanghai Fudan University , Shanghai, China.
- Department of Pathology, Fifth People's Hospital of Shanghai Fudan University , Shanghai, China.
ORCID-Profile: Bingbing Zha
Zitieren
APA
Zhang, Q., Tang, J., Yang, J., Li, Y., Li, X., Wang, K., Zhang, P., Wang, K., & Zha, B. (2026). Protective TGFβ2/SMAD3 axis identified by TWAS in papillary thyroid cancer. Endocrine-Related Cancer, 33(8). https://doi.org/10.1530/erc-25-0405
Vancouver
Zhang Q, Tang J, Yang J, Li Y, Li X, Wang K, et al. Protective TGFβ2/SMAD3 axis identified by TWAS in papillary thyroid cancer. Endocrine-Related Cancer. 2026;33(8). doi:10.1530/erc-25-0405
BibTeX
@article{Zhang2026,
author = {Zhang, Qinnan and Tang, Jiayu and Yang, Ju and Li, Yujin and Li, Xueqing and Wang, Kangan and Zhang, Panpan and Wang, Kai and Zha, Bingbing},
title = {Protective TGFβ2/SMAD3 axis identified by TWAS in papillary thyroid cancer},
journal = {Endocrine-Related Cancer},
year = {2026},
volume = {33},
number = {8},
doi = {10.1530/erc-25-0405}
}
EUVIMED